OUR ACTIVITIES
Mandatory subjects
Mandatory courses
Integrated study programme “Pharmacy”:
- “Pharmacogenomics and Drug Metabolism” for the 3rd year students;
- Module “Pharmaceutical Chemistry” for the 3rd year students;
- Module “Drug Chemistry” for the 4th year students;
- Part “Quality of drugs” of the module “Development of Pharmaceutical Products” for the 5th year students;
- Part “Organisation and evaluation of practice in drug analysis in pharmacy” of the module “Professional Practice in Pharmacy” for the 5th year students;
- Final Master’s thesis for the 4th and 5th year students;
- Elective courses: “Development of drug substances”, “Interactions between antibiotics, bacteria and the macro-organism”.
First-cycle study programme “Medical and Veterinary Biochemistry” (Faculty of Medicine):
- “Pharmaceutical Biochemistry” for the 3rd year students.
Second-cycle joint KTU-LSMU study programme “Medicinal Chemistry”:
- Part “Pharmaceutical Chemistry” of the module “Pharmacognosy and Pharmaceutical Chemistry” for the 1st year students.
- Synthesis, analysis and study of the effects of biologically active compounds on living organisms.
- In vitro development of cell models for the studies of the efficacy of new drugs.
- Search and study of plant-derived multifactorial antioxidants.
- Studies on the effects of drugs and their metabolites on humans and microbiota.
Research commissioning contract with UAB ProBioSanus: “Qualitative Analysis of Metabolites of Probiotic Bacteria Bacillus and Lactobacillus sp” under Priority 1 “Promotion of Research, Experimental Development and Innovation” of the EU Funds Investment Operational Programme, Measure No. 012.1-MITA-K-824 “Innovation Vouchers”. Service period: 01/09/2017 to 28/02/2018. Value: EUR 4,000.
Cooperation with the framework of project “Exosome Application for Targeted Drug Delivery” (EXOTARGET) funded under measure No. 01.2.2-LMT-K-718-01-0036 “Targeted Research in Smart Specialisation Areas”. Implementation period: 2017–2022. Project manager: Dr. Aistė Jekabsone. Project value: EUR 499,872.20. Project implementers: Prof. R. Morkūnienė, PhD student G. Vydmantaitė.
Cooperation with the Institute of Pharmaceutical Technologies under Measure No. J05-LVPA-K-01-0248 “Intellect. Joint Science-Business Projects“: “Promotion of UAB Akvavita investments in R&D activities by developing innovative products in the beverage industry”. Project manager Prof. Dr. V. Jakštas. Project value: EUR 315,887.22. Project implementer: Prof. R. Morkūnienė.
Cooperation under the bilateral research project of Lithuania and Japan by the Neuroscience Institute: “Study of the molecular determinants of Alzheimer’s disease: the relationship between extracellular tau, beta amyloid, and neuroinflammation” (INFLAMATAU), the Research Council of Lithuania. Source of funding: the Research Council of Lithuania. Implementation period: 2018–2020. Project manager: R. Morkūnienė.
Joint LSMU-KTU project “Generation of o-Quinone Methides and Investigation Their Conjugates and Metabolites in Saccharomyces Cerevisiae Lag and Log Phases” (CHINONMETIDAS). Project manager: R. Morkūnienė. Project implementer: L. Šlepikas. Source of funding: the LSMU Research Fund, 2019.
Cooperation under project No. 01.2.2-LMT- K-718-01-0038 “Point-of-Care method for ticagrelor pharmacogenomics” (OPTOGEN) jointly funded from the structural funds of the European Union, coordinated by the Institute of Cardiology. Project implementer: V. Tatarūnas. Source of funding: the Research Council of Lithuania, SMART project funds.
Cooperation with UAB SynHet (headed by L. Šlepikas) under project No. 01.2.1-LVPA-K-856-01-0188 “Development of high potency compounds against S. aureus based on the in silico chemogenomics, in vitro and in vivo studies”. Implementation period: 2020-2022. Project value: EUR 534,061.00
Cooperation with UAB SynHet (headed by L. Šlepikas) under project No. 01.2.2-MITA-K-702-06-0018 “Development of the adaptive robotic separation system”. Implementation period: 2020-2021. Project value: EUR 99,000.
Cooperation under project No. 01.2.2-LMT-K-718-05-0052 “Technology for the management of COVID-19-induced mitochondrial dysfunction of cardiovascular system” (cTECH) coordinated by the Institute of Cardiology. Project manager: Dr. Aistė Jekabsone. Project value: EUR 299,965.66. Implementation period: 2021-2023. Project manager: PhD student G. Vydmantaitė.
Cooperation with UAB SynHet (headed by L. Šlepikas) under project BIOTECH-02-006 “Development of in silico chemogenomics-based biologically active compounds against K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter spp.”. Project manager: Liudas Ivanauskas. Project value: EUR 194,793.00.
Neuroscience Institute of LSMU
Institute of Cardiology of LSMU
Department of Biochemistry of LSMU
Life Sciences Centre
State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania
Kharkiv National University of Pharmacy, Department of Pharmaceutical Chemistry (Ukraine)
Medical University of Bialystok, Department of Pharmaceutical and Bio-Pharmaceutical Analysis (Poland)
Odessa National Medical University, Faculty of Pharmacy (Ukraine)
University of Copenhagen, Department of Neuroscience (Denmark)
University of Tartu, Institute of Pharmacy under the Faculty of Medicine (Estonia)
Houston Methodist Research Institute, Department of Nanomedicine (the U.S.)
Association of the European Self-Medication Industry
Business partners: UAB SynHet, UAB Ferentis, UAB Aconitum
Kopenhagos Universiteto (Danija) Neuromokslų departamentas
Tartu universiteto (Estija) Medicinos fakulteto Farmacijos institutas
Hjustono metodistų mokslo instituto (JAV) Nanomedicinos departamentas
Europos savarankiškų vaistų (Self-Medication) pramonės asociacija
Verslo partneriai: UAB „SynHet“, UAB „Ferentis“, UAB “Aconitum“
